摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(((2,6-diisopropylphenyl)imino)methyl)-6-methylphenol | 1031691-15-2

中文名称
——
中文别名
——
英文名称
2-(((2,6-diisopropylphenyl)imino)methyl)-6-methylphenol
英文别名
2-Me-6-(2,6-iPr2C6H3)N=CHC6H3OH;HO-2-Me-6-((2,6-(i-Pr)2C6H3)N=CH)C6H3;2-[[2,6-di(propan-2-yl)phenyl]iminomethyl]-6-methylphenol
2-(((2,6-diisopropylphenyl)imino)methyl)-6-methylphenol化学式
CAS
1031691-15-2
化学式
C20H25NO
mdl
——
分子量
295.425
InChiKey
JAMLJLKYKYJDKR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    32.6
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    (五甲基环戊二烯基)三氯化钛(IV)2-(((2,6-diisopropylphenyl)imino)methyl)-6-methylphenol 在 CH3(CH2)3Li 作用下, 以 乙醚正己烷 为溶剂, 以59.1%的产率得到Cp*TiCl2[O-2-Me-6-[(2,6-iPr2C6H3)N=CH]C6H3]
    参考文献:
    名称:
    含苯氧基亚胺配体的半茂钛化合物的合成及其在烯烃聚合反应中的应用
    摘要:
    各种含有Cp'TiCl 2 [O-2-R 1 -6-(R 2 N CH)C 6 H 3 ]型苯氧基亚胺配体的半钛茂金属[Cp'= Cp *(C 5 Me 5)和R 1,R 2 = Me,2,6- iPr 2 C 6 H 3(1);Pr 2 C 6 H 3(1)。Ť卜2,6-我Pr 2 C 6 H 3(2); 我,t卜(3); Ť卜,Ť卜(4); Cp'= 1,2,4-Me 3 C 5 H 2和R 1,R 2 = Me,2,6- iPr 2 C 6 H 3(5);Pr 2 C 6 H 3(5)。Cp'= Cp和R 1,R 2 = Me,2,6- iPr 2 C 6 H 3(6);Pr 2 C 6 H 3(6)。我,tBu(7)]是通过Cp'TiCl 3与LiO-2-R 1 -6-(R 2 N CH)C 6 H 3反应制得的,而LiO-2-R 1 -6-(R 2 N CH)C 6 H 3是通过用n
    DOI:
    10.1021/om700660b
  • 作为产物:
    描述:
    2,6-二异丙基苯胺2-羟基-3-甲基苯甲醛甲醇乙醇正己烷 为溶剂, 以79 %的产率得到2-(((2,6-diisopropylphenyl)imino)methyl)-6-methylphenol
    参考文献:
    名称:
    苯氧亚胺配体支持的钛 (IV) μ-Oxo 络合物:合成、晶体结构表征、DFT 和分子对接研究
    摘要:
    :在室温、氮气气氛下,丁醇钛与苯氧亚胺配体以 1:1 化学计量在甲苯中反应,合成了一种新的晶体配合物 [Ti{La}]。该复合物已通过各种光谱和分析技术进行了表征。通过 X 射线衍射分析的合适晶体确定了具有六配位钛中心的稳定双核 μ-氧配合物的形成。该晶体呈单斜晶系,空间群为C 1 2/c 1。X射线晶体结构分析表明,该配合物具有菱形Ti-O-Ti核,并表现出具有扭曲八面体几何形状的C2对称构象。新合成的Ti配合物进行了密度泛函理论和对接研究。使用 B3LYP 和 6-31+G 基组对激活物质进行了密度泛函理论 (DFT) 计算,深入了解了前沿轨道和 Mulliken 电荷分析,这与实验结果显示出良好的相关性。此外,针对 HER2 抑制剂激酶进行了配体和复合物的计算机分子对接。该复合物与 HER2 (PDB:7JXH) 活性口袋的结合能 ΔGb = -19.7 kcal/mol 比配体 ΔGb
    DOI:
    10.2174/1570180820666230714141927
点击查看最新优质反应信息

文献信息

  • Synthesis of Al complexes containing phenoxy-imine ligands and their use as the catalyst precursors for efficient living ring-opening polymerisation of ε-caprolactone
    作者:Jingyu Liu、Naruhito Iwasa、Kotohiro Nomura
    DOI:10.1039/b801561a
    日期:——
    Al complexes containing phenoxy-imine ligands of type, Me2Al[O-2-R1-6-(R2NCH)C6H3] [R1 = Me, R2 = 2,6-iPr2C6H3 (1a), tBu (1b); R1 = tBu, R2 = 2,6-iPr2C6H3 (2a), tBu (2b), cyclohexyl (2c), adamantyl (2d), C6H5 (2e), 2,6-Me2C6H3 (2f), C6F5 (2g)] have been prepared in high yields from AlMe3 by treating with 1.0 equiv. of 2-R1-6-(R2NCH)C6H3OH in n-hexane. Structures for 1a, 1b, 2a–e and 2g were determined by X-ray crystallography, and these complexes have a distorted tetrahedral geometry around Al; both the Al–O and the Al–N bond distances were influenced by substituents in both the aryloxo and the imino groups. Me2Al[μ2-O-2-(R2NCH)C6H4](AlMe3) [R2 = 2,6-iPr2C6H3 (3a), tBu (3b)] were prepared exclusively by reaction of AlMe3 with 2-(R2NCH)C6H4OH, and these complexes form a distorted tetrahedral geometry around each Al centre with additional AlMe3 coordinating to the oxygen in the phenoxy-imine ligand. Complexes 1a, 1b and 2a–g were tested as catalyst precursors for ring-opening polymerisation (ROP) of ε-caprolactone (CL) in the presence of nBuOH (1.0 equiv. to Al), and their catalytic activities were strongly influenced by the imino substituent (R2). The efficient ROP has been achieved using the C6F5 analogue (2g), with the ROP taking place in a living manner.
    含有苯氧亚胺配体类型的 Al 配合物 Me2Al[O-2-R1-6-(R2NCH)C6H3] [R1 = Me, R2 = 2,6-iPr2C6H3 (1a), tBu (1b); R1 = tBu, R2 = 2,6-iPr2C6H3 (2a), tBu (2b), cyclohexyl (2c), adamantyl (2d), C6H5 (2e), 2,6-Me2C6H3 (2f), C6F5 (2g)],通过在 n-己烷中用 1.0 当量的 2-R1-6-(R2NCH)C6H3OH 处理 AlMe3 高产率地制备。通过 X 射线晶体学确定了 1a, 1b, 2a–e 和 2g 的结构, 这些配合物在 Al 周围具有扭曲的四面体几何结构; Al–O 和 Al–N 键距离都受到 aryloxo 和 imino 基团中取代基的影响。 Me2Al[μ2-O-2-(R2NCH)C6H4](AlMe3) [R2 = 2,6-iPr2C6H3 (3a), tBu (3b)], 通过 AlMe3 与 2-(R2NCH)C6H4OH 的反应独有地制备, 这些配合物在每个 Al 中心周围形成扭曲的四面体几何结构, 并额外有 AlMe3 与苯氧亚胺配体中的氧配位。 1a, 1b 和 2a–g 被测试为环开聚合 (ROP) 的催化剂前体, 在 nBuOH (相对于 Al 为 1.0 当量) 存在下进行 ε-己内酯 (CL) 的 ROP, 其催化活性强烈受到 imino 取代基 (R2) 的影响。使用 类似物 (2g) 实现了高效的 ROP, 其中 ROP 以活性方式进行。
  • Synthesis and Structural Analysis of (Arylimido)vanadium(V) Complexes Containing Phenoxyimine Ligands: New, Efficient Catalyst Precursors for Ethylene Polymerization
    作者:Yoshifumi Onishi、Shohei Katao、Michiya Fujiki、Kotohiro Nomura
    DOI:10.1021/om800177g
    日期:2008.6.9
    (arylimido)vanadium(V) complexes containing phenoxyimine ligands of the type V(NAr)Cl2[O-2-R-6-(2,6-iPr2C6H3)N═CH}C6H3] [Ar = 2,6-Me2C6H3; R = H (1a), Me (1b), tBu (1c)] have been prepared in 64−78% yields from V(NAr)Cl3 with LiO-2-R-6-[(2,6-iPr2C6H3)N═CH]C6H3. The structures for 1a−c determined by X-ray crystallography indicate that these complexes have distorted square-pyramidal structures around vanadium
    一系列含(V)(NAr)Cl 2 [O-2-R-6-(2,6- i Pr 2 C 6 H 3)N═CH}类型的苯氧亚胺配体的(芳基基)(V)络合物C 6 H 3 ] [Ar = 2,6-Me 2 C 6 H 3;R = H(1a),Me(1b),t Bu(1c)]已由V(NAr)Cl 3和LiO-2-R-6-[(2,6- i Pr 2 C 6 H 3)N═CH] C 6 H 3。的结构通过X射线晶体学测定的1a - c表明这些络合物在周围具有扭曲的方锥体结构,该结构由扭曲的方锥体顶部的芳基配体和形成平面的N,O-螯合物组成包括芳基氧代环和亚基氮。1c [90.49(2)°]的Cl-V-Cl键角明显小于1a,b [91.97(7)°,91.25(2)°]和V-N(亚胺)的键角1c [2.203(2)Å]中的键距比1b,c [分别为[2.216(4),2.2165(17)Å]中的键距
  • Bis-Salicylaldiminato Complexes of Zinc. Examination of the Catalyzed Epoxide/CO<sub>2</sub> Copolymerization
    作者:Donald J. Darensbourg、Patrick Rainey、Jason Yarbrough
    DOI:10.1021/ic0006403
    日期:2001.2.1
    A series of salicylaldimine ligands of the general formula ((NRC7H5-x)-C-2(R-1)(x)OH) [x = 1 or 2; R-1 = Me, (BU)-B-t, Cl, OMe: R-2 = 2 6-(Pr2C6H3)-Pr-1, or 3,5-(CF3)(2)C6H3] have been synthesized and characterized via H-1 and C-13 NMR, elemental analysis, and X-ray crystallography. The concomitant series of zinc bis(salicylaldiminato) complexes of the general formula ((NRC7H5-x)-C-2(R-1)(x)O)(2)Zn have been synthesized and characterized in the solid state by X-ray crystallography. All complexes crystallized as four coordinate monomers with distorted tetrahedral geometry about the zinc center. The O-Zn-O angles range between 105 and 112.5 degrees, and the N-Zn-N bond angles were more obtuse spanning the range 122.9-128.9 degrees The only deviation from distorted tetrahedral geometry occurred when R-2 = 3,5-(CF3)(2)C6H3 which crystallized as a distorted trigonal bipyramidal dimeric species with O-ax-Zn-O-ax bond angles of 165.00(15)degrees. The equatorial angles approach 120 degrees except for the N-eq-Zn-N-eq angle of 110.54(16)degrees which is attributed to the strain of the bridging ligands. The zinc bis(salicylaldiminato) complexes showed varying activities as catalyst precursors for the copolymerization of CO2 and cyclohexene oxide. Activation is proposed to occur via CO, insertion in the phenolic Zn-O bond with simultaneous ring-opening resulting in a site for epoxide binding. The difference in activity has been ascribed to the different steric/electronic effects provided by the R-1 and R-2 substituents an the various steps of the copolymerization mechanism, The activity of the zinc bis(salicyaldiminato) catalyst precursors (< 16 gpoly/m/g . Zn/hr) were similar to the activities of the previously reported zinc phenoxide complexes for this reaction: however, unlike; the zinc phenoxide catalysts, the zinc bis(salicylaldiminato) complexes produced poly(cyclohexane carbonate) with greater than 99% carbonate linkages.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫